Rice Hall James & Associates’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-413,537
Closed -$15.8M 312
2017
Q4
$15.8M Sell
413,537
-26,530
-6% -$1.06M 0.62% 68
2017
Q3
$16.5M Sell
440,067
-19,530
-4% -$689K 0.73% 60
2017
Q2
$17.1M Sell
459,597
-2,449
-0.5% -$88.5K 0.75% 63
2017
Q1
$18.1M Sell
462,046
-12,270
-3% -$460K 0.88% 46
2016
Q4
$16.5M Sell
474,316
-9,165
-2% -$360K 0.83% 51
2016
Q3
$19M Sell
483,481
-2,674
-0.6% -$107K 0.99% 33
2016
Q2
$18.4M Sell
486,155
-7,252
-1% -$243K 1.06% 21
2016
Q1
$19M Sell
493,407
-515
-0.1% -$19.2K 1.09% 26
2015
Q4
$23.7M Sell
493,922
-5,851
-1% -$271K 1.36% 9
2015
Q3
$19.7M Buy
499,773
+302
+0.1% +$12.8K 1.28% 17
2015
Q2
$21.3M Buy
499,471
+159,996
+47% +$6.38M 1.23% 16
2015
Q1
$13.4M Buy
339,475
+237,830
+234% +$8.77M 0.78% 49
2014
Q4
$3.66M Sell
101,645
-276
-0.3% -$9.27K 0.22% 111
2014
Q3
$3.01M Sell
101,921
-1,647
-2% -$45.4K 0.21% 119
2014
Q2
$2.6M Sell
103,568
-839
-0.8% -$20.7K 0.18% 155
2014
Q1
$2.69M Sell
104,407
-72,324
-41% -$1.82M 0.2% 147
2013
Q4
$3.98M Sell
176,731
-8,200
-4% -$158K 0.29% 76
2013
Q3
$2.62M Sell
184,931
-1,600
-0.9% -$21.4K 0.25% 132
2013
Q2
$2.55M Buy
+186,531
New +$2.54M 0.25% 115

Other funds holding NTUS

Rice Hall James & Associates's NTUS Position: Q1 2018 in Review

Rice Hall James & Associates sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 413,537 shares — an estimated $15.8M sold.

Rice Hall James & Associates first reported a position in NTUS in Q2 2013 and held it in 19 quarters. The position peaked at $23.7M in Q4 2015. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

  • Rice Hall James & Associates reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
  • Rice Hall James & Associates sold 413,537 Natus Medical Inc shares in Q1 2018, an estimated $15.8M.
  • Rice Hall James & Associates first reported a position in Natus Medical Inc in Q2 2013 and held it in 19 quarters.
  • Rice Hall James & Associates's Natus Medical Inc position peaked at $23.7M in Q4 2015.
  • 184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on Rice Hall James & Associates's 13F filing for Q1 2018, filed 25 Apr 2018.